Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Seven medical personnel experienced severe fever and thrombocytopenia syndrome (SFTS) in a rare case of human-to-human ...

A recent trial reveals that nivolumab combined with chemotherapy significantly improves survival rates in older patients with ...

Finding an effective, safe medication to control itch is essential to maximize patient comfort. Because Zenrelia does not require a loading dose and is administered once daily, Zenrelia may help impro ...

Early results from the MagnetisMM-6 trial reveal promising efficacy of elranatamab, daratumumab, and lenalidomide in treating ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new ...

Sanofi’s SNY stock has been trading below its 200-day and 50-day moving averages since early June. On June 23, the stock’s ...

Meropenem is a broad-spectrum carbapenem widely used to treat both Gram-positive and negative bacterial infections, including extended-spectrum beta-lactamase-producing microbes. We describe the ...

Iron Iron powers the "energy cells" of platelets (called mitochondria) and makes them more efficient. Severe iron deficiency can lead to thrombocytopenia. You can find good sources of iron in ...

In TP53 wild-type advanced or recurrent endometrial cancer, selinexor improved multiple time-to-event outcomes vs placebo.

However, in the setting of severe thrombocytopenia (e.g., platelets <30,000/µL), anticoagulation is generally withheld or used with extreme caution due to the risk of bleeding. In cases of ITP ...